Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the addition of a companion diagnostic (CDx) indication to its CE-marked in vitro …
https://finance.yahoo.com/news/illumina-introduces-pan-cancer-companion-060000307.html